GSK Plc ADR [GSK] stock is trading at $46.94, up 2.20%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GSK shares have gain 3.07% over the last week, with a monthly amount glided 3.14%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GSK Plc ADR [NYSE: GSK] stock has seen the most recent analyst activity on June 03, 2025, when Berenberg downgraded its rating to a Hold. Previously, Exane BNP Paribas started tracking the stock with Neutral rating on April 15, 2025, and set its price target to $35.25. On February 12, 2025, Morgan Stanley initiated with a Equal-Weight rating. Deutsche Bank downgraded its rating to a Hold. Jefferies downgraded its rating to a Hold and reduced its price target to $39.50 on November 12, 2024. Guggenheim downgraded its rating to Neutral for this stock on October 31, 2024. In a note dated July 08, 2024, UBS downgraded an Neutral rating on this stock.
GSK Plc ADR [GSK] stock has fluctuated between $31.72 and $46.87 over the past year. Currently, Wall Street analysts expect the stock to reach $53 within the next 12 months. GSK Plc ADR [NYSE: GSK] shares were valued at $46.94 at the most recent close of the market. An investor can expect a potential return of 12.91% based on the average GSK price forecast.
Analyzing the GSK fundamentals
GSK Plc ADR [NYSE:GSK] reported sales of 42.06B for the trailing twelve months, which represents a growth of 10.64%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.24 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 46.12 points at the first support level, and at 45.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 47.46, and for the 2nd resistance point, it is at 47.98.
Ratios To Look Out For
For context, GSK Plc ADR’s Current Ratio is 0.84. As well, the Quick Ratio is 0.55, while the Cash Ratio is 0.18. Considering the valuation of this stock, the price to sales ratio is 2.24, the price to book ratio is 4.35 and price to earnings (TTM) ratio is 13.39.
